CCM
VNDA icon

Convector Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Convector Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-70,000
Closed -$783K – 29
2016
Q2 		$783K Sell
70,000
-62,000
-47% -$600K 1.08% 26
2016
Q1 		$1.1M Buy
132,000
+3,500
+3% +$28.7K 1.12% 26
2015
Q4 		$1.2M Buy
+128,500
New +$1.28M 1.13% 26

Other funds holding VNDA

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Convector Capital Management's VNDA Position: Q3 2016 in Review

Convector Capital Management sold out of Vanda Pharmaceuticals (VNDA) in Q3 2016, closing a stake of 70,000 shares — an estimated $783K sold.

Convector Capital Management first reported a position in VNDA in Q4 2015 and held it in 3 quarters. The position peaked at $1.2M in Q4 2015. 140 funds tracked by Wall St. Rank hold VNDA as of Q3 2016.

  • Convector Capital Management reported no remaining Vanda Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Convector Capital Management sold 70,000 Vanda Pharmaceuticals shares in Q3 2016, an estimated $783K.
  • Convector Capital Management first reported a position in Vanda Pharmaceuticals in Q4 2015 and held it in 3 quarters.
  • Convector Capital Management's Vanda Pharmaceuticals position peaked at $1.2M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2016.

Based on Convector Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.